As of 11:53:48 AM EST. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INBX | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Initiated | JMP Securities: Market Perform | 7/23/2024 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 1/23/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 11/20/2023 |
| Maintains | JMP Securities: Outperform to Outperform | 8/23/2023 |
| Reiterates | JMP Securities: Market Outperform | 5/10/2023 |
| Maintains | JMP Securities: Market Outperform | 3/8/2023 |
Related Tickers
MRVI Maravai LifeSciences Holdings, Inc.
5.56
+1.93%
ITOS iTeos Therapeutics, Inc.
7.95
+3.52%
ROIV Roivant Sciences Ltd.
12.11
+2.37%
KYMR Kymera Therapeutics, Inc.
41.50
+3.14%
TVGN Tevogen Bio Holdings Inc.
1.0696
+3.84%
VCEL Vericel Corporation
56.82
+3.48%
ORIC ORIC Pharmaceuticals, Inc.
8.24
+2.11%
NRIX Nurix Therapeutics, Inc.
19.66
+4.35%
KROS Keros Therapeutics, Inc.
16.43
+3.79%
JANX Janux Therapeutics, Inc.
57.14
+6.72%